5th December 2019
USADA announced today that Lawrence Letellier, of San Angelo, Texas, an athlete in the sport of weightlifting, has accepted a two-year suspension for an anti-doping rule violation.
Letellier, 34, tested positive for clomiphene as the result of an in-competition drug test conducted at the American Open Series 2 on July 27,2019.
Clomiphene is a Specified Substance in the class of Hormone and Metabolic Modulators and is prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policies, and the International Weightlifting Federation Anti-Doping Policy, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
Letellier’s two-year period of ineligibility began on July 27, 2019, the date his positive sample was collected. In addition, Letellier has been disqualified from competitive results obtained on and subsequent to July 27, 2019, including forfeiture of any medals, points and prizes.
- Anti-Doping Rule Violation Athlete Hormone and Metabolic Modulators International Weightlifting Federation Anti-Doping Policy Prohibited Substance Specified Substance United States Olympic and Paralympic Committee National Anti-Doping Policies USADA Protocol for Olympic and Paralympic Movement Testing Weightlifting World Anti-Doping Agency Prohibited List_ World Anti-Doping Code